针中的:恶意注射和毒性的案例
Naghmeh Kian1, Mitra Rahimi2, Shahin Shadnia2
1School of Medicine Shahid Beheshti University of Medical Sciences Tehran Iran.
Clinical case reports
|February 13, 2026
概括
本案例报告详细介绍了一例罕见的皮下注射毒性病例. 一名妇女在注射后出现了部病变,呈现出高水平,但很少出现全身症状,突出显示了不寻常的呈现和治疗反应.
科学领域:
- 毒理学 毒理学 毒理学
- 皮肤病学 皮肤病学
- 案例报告 案例报告
背景情况:
- 毒性通常是由于摄入或吸入而产生的.
- 皮下注射非常罕见,通常与意外或故意的自我伤害有关.
- 报告的病例通常涉及疼痛性颗粒瘤,不常见的系统性参与.
研究的目的:
- 在皮下注射后报告一种独特的毒性病例.
- 描述这种罕见疾病的临床表现,诊断结果和治疗方法.
- 讨论潜在的不寻常的暴露途径和中毒的意图.
主要方法:
- 一个39岁的女性患者的详细临床病例介绍.
- 分析患者病史,体检结果和实验室结果 (血清水平).
- 用 succimer 治疗的记录以及随后的临床结果.
主要成果:
- 患者在接受注射后出现了局部,疼痛的脏病变,其中含有.
- 血清水平显著升高 (345μg/L),尽管系统性症状最小.
- 用苏基默治疗导致水平下降.
结论:
- 皮下注射可以导致局部毒性,系统性表现惊人地低.
- 这一案例代表了一种罕见的中毒现象,可能涉及谋杀意图.
- 及时诊断和化疗法对于管理毒性至关重要,无论暴露途径如何.
更多相关视频
05:18Author Spotlight: Ultrasound-Guided Needle Release Combined with Corticosteroid Injection for the Treatment of Supinator Syndrome
Published on: May 26, 2023
1.9K
12:59A Study of the Complexation of MercuryII with Dicysteinyl Tetrapeptides by Electrospray Ionization Mass Spectrometry
Published on: January 8, 2016
8.4K
相关概念视频
Toxicity Testing in Animals
1
Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
1
Toxic Reactions: Overview
2.2K
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
2.2K
Drug Toxicity: Overview
2
Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
2
Bioactivation and Tissue Toxicity
1
Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
1
Drug Toxicity: Risk factors
2
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
2
Drug toxicity: Idiosyncratic Reactions
3
Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
3
